Canopy Growth (CGC) Other Non-Current Liabilities (2017 - 2026)

Canopy Growth (CGC) reported Other Non-Current Liabilities of $27.3 million for Q1 2026, up 7.81% on a YoY basis from $25.3 million in Q1 2025, and up 244.31% sequentially from $7.9 million in Q4 2025.

Canopy Growth (CGC) Other Non-Current Liabilities (2017 - 2026) Analysis & Trends

Canopy Growth (CGC) has 10 years of Other Non-Current Liabilities data on file, last reported at $27.3 million in Q1 2026.

  • For the quarter ending Q1 2026, Other Non-Current Liabilities rose 7.81% year-over-year to $27.3 million; the trailing twelve-month figure through Mar 2026 stood at $27.3 million (up 7.81% YoY), and the FY2026 full-year result was $27.3 million, up 7.81% from the prior year.
  • Other Non-Current Liabilities advanced to $27.3 million in Q1 2026, from $7.9 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $73.4 million in Q2 2023 to a low of $529821.7 in Q3 2022.
  • A 5-year average of $25.4 million and a median of $22.6 million in 2022 frame the typical range for Other Non-Current Liabilities.
  • Across the five-year window, Other Non-Current Liabilities slumped 99.37% in 2022 and surged 2808.56% in 2023, its largest moves.
  • Tracing CGC's Other Non-Current Liabilities over 5 years: stood at $29.4 million in 2022, then plunged by 76.19% to $7.0 million in 2023, then soared by 242.51% to $24.0 million in 2024, then sank by 66.97% to $7.9 million in 2025, then soared by 244.31% to $27.3 million in 2026.
  • Business Quant data shows CGC's Other Non-Current Liabilities at $27.3 million in Q1 2026, $7.9 million in Q4 2025, and $11.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Canopy Growth 197.77 Mn -68.15 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 27.25 Mn
Dec 31, 2025 7.92 Mn
Sep 30, 2025 11.13 Mn
Jun 30, 2025 8.65 Mn
Mar 31, 2025 25.28 Mn
Dec 31, 2024 23.97 Mn
Sep 30, 2024 33.25 Mn
Jun 30, 2024 48.11 Mn
Mar 31, 2024 53.29 Mn
Dec 31, 2023 7.00 Mn
Sep 30, 2023 15.41 Mn
Jun 30, 2023 73.36 Mn
Dec 31, 2022 29.39 Mn
Sep 30, 2022 529,821.66
Jun 30, 2022 20.86 Mn
Mar 31, 2022 21.25 Mn
Dec 31, 2021 155.19 Mn
Sep 30, 2021 84.06 Mn
Jun 30, 2021 88.71 Mn
Mar 31, 2021 486.37 Mn